This is Part 3 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 2). Use of CROs in research and drug development...

This is Part 2 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 3). Contract research organizations (CROs) often...

Successful life science startup entrepreneurs share the basics on starting a business. Aspiring entrepreneurs received advice from an optimistic...

Cell culture is the foundation of high throughput screening during drug development. However, it is well known that there is a big and precarious...

Kevin Lustig was invited by The Empowered Patient Radio Show after they heard Kevin at the Tech Coast Angels quick pitch competition. Kevin...

This is Part 1 in a three-part series on key factors in CRO selection. (Check out Part 2 and Part 3). Alternative strategies for approaching drug...

The next time your research takes you outside your field of expertise, you might consider looking for a core lab to help move your project forward...

Dr. Kevin Lustig talks about strategic outsourcing and bringing pharma and drug discovery into the information age in an article he recently wrote...

Amidst the many challenges facing the life sciences industry today such as diminishing funding sources, increased costs to develop new drugs and...

Core labs are important assets to academic institutions. They are concentrated pockets of experts, to whom scientists can outsource specific parts...